FOSAPREPITANT DIMEGLUMINE for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where FOSAPREPITANT DIMEGLUMINE was used for Breast cancer.
Most Reported Side Effects for FOSAPREPITANT DIMEGLUMINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 142 | 16.0% | 39 | 69 |
| Pyrexia | 136 | 15.3% | 34 | 109 |
| Nausea | 130 | 14.6% | 29 | 75 |
| Infusion related reaction | 83 | 9.4% | 37 | 50 |
| Diarrhoea | 80 | 9.0% | 27 | 62 |
| Vomiting | 71 | 8.0% | 31 | 54 |
| Rash | 66 | 7.4% | 33 | 50 |
| Hypersensitivity | 65 | 7.3% | 37 | 46 |
| Stomatitis | 64 | 7.2% | 34 | 51 |
| Decreased appetite | 62 | 7.0% | 26 | 40 |
| Pain | 62 | 7.0% | 33 | 47 |
| Drug ineffective | 60 | 6.8% | 24 | 40 |
| Insomnia | 60 | 6.8% | 38 | 49 |
| Abdominal pain | 59 | 6.6% | 23 | 39 |
| Neutropenia | 58 | 6.5% | 7 | 34 |
Other Indications for FOSAPREPITANT DIMEGLUMINE
Prophylaxis of nausea and vomiting (551)
Product used for unknown indication (78)
Nausea (23)
Premedication (18)
Vomiting (16)
Chemotherapy (10)
Antiemetic supportive care (9)
Covid-19 (5)
Lung adenocarcinoma metastatic (5)
Rheumatoid arthritis (5)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)